Sputum MMP-12 concentration and enzyme activity in COPD and asthma in relation to smoking status and disease severity
R. Chaudhuri, I. Donnelly, C. Grierson, P. Lapan, J. Brady, L. Jolly, C. Weir, C. Messow, C. McSharry, M. Spears, D. Miller, N. Thomson (Glasgow, Dundee, United Kingdom; Collegeville, United States Of America)
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Chaudhuri, I. Donnelly, C. Grierson, P. Lapan, J. Brady, L. Jolly, C. Weir, C. Messow, C. McSharry, M. Spears, D. Miller, N. Thomson (Glasgow, Dundee, United Kingdom; Collegeville, United States Of America). Sputum MMP-12 concentration and enzyme activity in COPD and asthma in relation to smoking status and disease severity. Eur Respir J 2010; 36: Suppl. 54, 5497
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Proteolytic activity of sputum and serum in patients with COPD exacerbation in dependence on smoking Source: Eur Respir J 2003; 22: Suppl. 45, 416s Year: 2003
Leptin levels in induced sputum from patients with COPD are sensitive to smoking status Source: Eur Respir J 2005; 26: Suppl. 49, 660s Year: 2005
Systemic inflammation in COPD in relation to smoking status Source: Virtual Congress 2020 – Smoking disease landscape: from inflammation to lung function and comorbidities Year: 2020
CC10 and TIMP1 levels in induced sputum of smokers who developed chronic airflow impairment Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking Year: 2005
The effect of smoking on the activity of inflammatory markers in patients with COPD Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease Year: 2013
Elevated sputum BPIFB1 levels correlate with progression of chronic obstructive pulmonary disease Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015
Contribution of TGFβ1 and TIMP2 to clinical activity of asthma and COPD Source: Annual Congress 2011 - Novel mechanisms in lung injury Year: 2011
Cytokines and MMP-9 level in serum and induced sputum of patients with suspicion of occupational COPD Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods Year: 2016
The tobacco smoking influence on parodontic inflammation in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 167s Year: 2007
Sputum biomarkers of inflammation in smokers and subjects with COPD Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013
Induced sputum in asthma and COPD: meassuring type and inflammation activity Source: Eur Respir J 2003; 22: Suppl. 45, 76s Year: 2003
CD8+ve airway inflammation in COPD: The impact of smoking status Source: Annual Congress 2003 - Cigarette smoke: how it does its dirty work Year: 2003
COPD disease progression and airway inflammation: uncoupled by smoking cessation Source: Eur Respir J 2005; 26: 764-766 Year: 2005
Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD Source: Eur Respir J 2004; 23: 685-691 Year: 2004
Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018
Overexpression of chitotriosidase and YKL-40 in serum and sputum in healthy smokers and patients with chronic obstructive pulmonary disease Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018
Decrease of physical activity in patients with COPD in the course of the disease Source: Annual Congress 2012 - The best abstracts in chronic care Year: 2012
Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013
Bronchial inflammation without asthma symptoms, relation to low neutrophil activity in serum Source: Eur Respir J 2002; 20: Suppl. 38, 143s Year: 2002
Relationship between age, sex, duration of asthma, asthma severity and deterioration of lung function in asthmatic patients Source: Eur Respir J 2001; 18: Suppl. 33, 33s Year: 2001